Corona Remedies Ltd Schedules Investor Conferences with Kotak Institutional Equities
Corona Remedies Ltd has scheduled a series of Investor Conferences and meetings, which will be attended by company officials. The events are organized in collaboration with Kotak Institutional Equities.The conferences are set for June 15, 2026, and June 16, 2026. These sessions, which include both one-on-one and group meetings, are slated to take place in London, United Kingdom, commencing at 09:00 AM BST on both days.
The details of the scheduled investor conferences are as follows:
| Date and Time | Organized by | Nature of Conferences | Place |
|---|---|---|---|
| June 15, 2026 & June 16, 2026 09:00 AM (BST) Onwards | Kotak Institutional Equities | 1x1 Meetings / Group | London, United Kingdom |
The company has confirmed that the discussions during these conferences will be based strictly on publicly available information. The officials of Corona Remedies Ltd have stated that no unpublished price sensitive information (UPSI) will be discussed during the scheduled meetings.
A note was also provided regarding the schedule, stating that changes may occur due to exigencies on the part of the Host or the Company.
CORONA Stock Price Movement
Shares of CORONA Remedies Limited are edging higher to ₹1774 as of 9:29 AM today, climbing by 0.18% in live trading. Trading activity remains measured this morning, with only 207 shares having changed hands so far into the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.